Endeavor Biomedicines has filed a notice of an exempt offering of securities to raise $132,583,908.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Endeavor Biomedicines is raising up to $132,583,908.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, John Hood played a…
